2015 (v1)
Publication
No description
Uploaded on: April 14, 2023
D
A
Last name: DE CENSI
First name: Andrea
No description
Premenopausal women with hormone receptor-positive early breast cancer are candidates for adjuvant endocrine therapy, as recommended by the major international guidelines. To date, adjuvant endocrine options for premenopausal women include tamoxifen with or without ovarian function suppression (OFS) or an aromatase inhibitor with OFS. Multiple...